Artisan Partners Asset Management Inc. Reports July 2017 Assets Under Management
Aug 09, 2017 20:32 pm UTC| Business
MILWAUKEE, Aug. 09, 2017 -- Artisan Partners Asset Management Inc. (NYSE:APAM) today reported that its assets under management (AUM) as of July 31, 2017 totaled $111.9 billion. Separate accounts accounted for $56.1...
Cidara Provides Corporate Update and Reports Second Quarter 2017 Financial Results
Aug 09, 2017 20:31 pm UTC| Business
SAN DIEGO, Aug. 09, 2017 -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today reported financial results for the three months ended June...
Goldfield Announces Second-Quarter 2017 Results
Aug 09, 2017 20:31 pm UTC| Business
MELBOURNE, Fla., Aug. 09, 2017 -- The Goldfield Corporation (NYSE American:GV), a leading provider of electrical construction services for the utility industry and industrial customers through its subsidiaries, Power...
Aug 09, 2017 20:30 pm UTC| Business
CORAL GABLES, Fla., Aug. 09, 2017 -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating...
Xcel Brands Announces Second Quarter 2017 Financial Results
Aug 09, 2017 20:30 pm UTC| Business
Company Expanding its Presence in Dillard’sSecond Quarter Net Revenues of $8.4 MillionSecond Quarter GAAP Net Income of $0.2 MillionSecond Quarter Non-GAAP Net Income of $1.5 Million; Adjusted EBITDA of $2.3 Million NEW...
Aug 09, 2017 20:30 pm UTC| Business
ARCA Estimates Reporting Top-line Phase 2B Data in the First Quarter of 2018Gencaro Development Program Has Been Granted Fast Track Designation by U.S. FDA WESTMINSTER, Colo., Aug. 09, 2017 -- ARCA biopharma, Inc....
XOMA to Present New Growth Strategy at the 2017 Wedbush PacGrow Healthcare Conference
Aug 09, 2017 20:30 pm UTC| Business
BERKELEY, Calif., Aug. 09, 2017 -- XOMA Corporation (Nasdaq:XOMA), a pioneer in the discovery and development of therapeutic antibodies, today announced that Jim Neal, Chief Executive Officer, will present the Company’s...